Factors of Influence in 2018, Key Indicators and Opportunity within Citigroup, Caesars Entertainment, 3M, First Industrial Realty, Nutanix, and CVS Health – New Research Emphasizes Economic Growth

Oct 31, 2017 11:31 am UTC| Business

NEW YORK, Oct. 31, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Citigroup Inc....

Protalix BioTherapeutics to Hold Third Quarter 2017 Financial Results and Corporate Update Conference Call on November 8, 2017

Oct 31, 2017 11:30 am UTC| Business

CARMIEL, Israel, Oct. 31, 2017 -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed...

TG Therapeutics, Inc. to Host Post ECTRIMS-ACTRIMS Conference Call to Review Data Presented on TG-1101 (ublituximab) in Multiple Sclerosis

Oct 31, 2017 11:30 am UTC| Business

Conference call to be held Thursday, November 2, 2017 at 8:30am ET   Edward Fox, MD, PhD, Director of the MS Clinic of Central Texas, and Principal Investigator for the Phase 2 Study, as featured guest speaker NEW...

Pure Energy Minerals Announces Positive New Results From Geophysical Exploration at Its Clayton Valley Lithium Project

Oct 31, 2017 11:30 am UTC| Business

DENVER, Oct. 31, 2017 -- Pure Energy Minerals Limited (TSX-V:PE) (OTCQB:PEMIF) (the “Company” or “Pure Energy”) is pleased to announce results from the latest phase of geophysical exploration at its Clayton Valley...

Intellia Therapeutics Announces Third Quarter 2017 Financial Results

Oct 31, 2017 11:30 am UTC| Business

First company to demonstrate dose-dependent CRISPR/Cas9 liver editing in non-human primates, including editing of over 20 percent in certain animals, following systemic delivery of Intellia’s proprietary, non-viral, lipid...

Mustang Bio Reports Preclinical Data on Regional Delivery of MB-103 HER2 Chimeric Antigen Receptor Engineered T (CAR T) Cells to Target HER2+ Breast Cancer Metastasis to the Brain

Oct 31, 2017 11:30 am UTC| Business

NEW YORK, Oct. 31, 2017 -- Mustang Bio, Inc. (“Mustang”) (NASDAQ:MBIO), a Fortress Biotech (NASDAQ:FBIO) Company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor...

Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes

Oct 31, 2017 11:30 am UTC| Business

MENLO PARK, Calif., Oct. 31, 2017 -- Geron Corporation (Nasdaq:GERN) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to imetelstat for the potential treatment...